Skip to content

CRUSTAL Study in China

Calcification Remodeling Utilizing Shockwave LiThotripsy in Coronary Artery CaLcification (Guangxi Real-World Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05828186
Enrollment
200
Registered
2023-04-25
Start date
2023-05-04
Completion date
2025-12-31
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcification, Coronary Artery Disease

Brief summary

This is a prospective, multicenter, single-arm registry study, aimed to evaluate the clinical outcomes of using Shockwave IVL catheter in the treatment of coronary artery calcification in real-world clinical practice.

Interventions

DEVICEShockwave Coronary Intravascular Lithotripsy (IVL) catheter

Patients with coronary artery calcification who are planned to undergo PCI and are deemed in need of Shockwave IVL catheter treatment by their physicians.

Sponsors

First Affiliated Hospital of Guangxi Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years. * Patients with coronary artery calcification who are planned to undergo PCI and are deemed in need of Shockwave IVL catheter treatment by their physicians. * The subject or their legal representative agrees to sign the informed consent form.

Exclusion criteria

* The physician evaluates that the subject's expected lifespan is \<1 year. * The subject did not receive IVL treatment in the index procedure. * The subject is pregnant or lactating. * The subject is currently participating in another clinical study.

Design outcomes

Primary

MeasureTime frameDescription
Procedure successin 48 hours post-procedure or prior to discharge, whichever comes firstProcedure success defined as successful stent implantation, residual stenosis degree \<30% (core laboratory), and no major adverse cardiac events (MACE) occurring during hospitalization
Freedom from major adverse cardiac events (MACE) within 30 days of the index procedure30 days post index procedureMACE is defined as: Cardiac death; or Myocardial Infarction (MI): Follow the Fourth Universal Definition of Myocardial Infarction ; or Target Vessel Revascularization (TVR) defined as revascularization at the target vessel (inclusive of the target lesion) after the completion of the index procedure; or Target lesion thrombosis.

Secondary

MeasureTime frameDescription
Vascular complications in the proudureImmediately post index procedureVascular complications is defined as: Perforation or Severe dissection or Acute occlusion or Consistent No-reflow/ slow flow
Incidence of target lesion revascularization30 days post index procedure
30 days post index procedure9 months post index procedure

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026